These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 10836327)
1. The bronchoprotective effect of inhaled salmeterol in preschool children: a dose-ranging study. Primhak RA; Smith CM; Yong SC; Wach R; Kurian M; Brown R; Efthimiou J Eur Respir J; 1999 Jan; 13(1):78-81. PubMed ID: 10836327 [TBL] [Abstract][Full Text] [Related]
2. A high dose of albuterol does not overcome bronchoprotective subsensitivity in asthmatic subjects receiving regular salmeterol or formoterol. Lipworth BJ; Aziz I J Allergy Clin Immunol; 1999 Jan; 103(1 Pt 1):88-92. PubMed ID: 9893190 [TBL] [Abstract][Full Text] [Related]
3. Inhaled corticosteroids do not prevent the development of tolerance to the bronchoprotective effect of salmeterol. Kalra S; Swystun VA; Bhagat R; Cockcroft DW Chest; 1996 Apr; 109(4):953-6. PubMed ID: 8635376 [TBL] [Abstract][Full Text] [Related]
4. Rapid onset of tolerance to the bronchoprotective effect of salmeterol. Bhagat R; Kalra S; Swystun VA; Cockcroft DW Chest; 1995 Nov; 108(5):1235-9. PubMed ID: 7587422 [TBL] [Abstract][Full Text] [Related]
5. Decreased bronchodilating effect of salbutamol in relieving methacholine induced moderate to severe bronchoconstriction during high dose treatment with long acting beta2 agonists. van der Woude HJ; Winter TH; Aalbers R Thorax; 2001 Jul; 56(7):529-35. PubMed ID: 11413351 [TBL] [Abstract][Full Text] [Related]
6. Tolerance to the bronchoprotective effect of salmeterol in adolescents with exercise-induced asthma using concurrent inhaled glucocorticoid treatment. Simons FE; Gerstner TV; Cheang MS Pediatrics; 1997 May; 99(5):655-9. PubMed ID: 9113940 [TBL] [Abstract][Full Text] [Related]
7. Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study. Nathan RA; Rooklin A; Schoaf L; Scott C; Ellsworth A; House K; Dorinsky P Clin Ther; 2006 Jan; 28(1):73-85. PubMed ID: 16490581 [TBL] [Abstract][Full Text] [Related]
8. Prevention of exercise-induced bronchospasm in pediatric asthma patients: a comparison of salmeterol powder with albuterol. Blake K; Pearlman DS; Scott C; Wang Y; Stahl E; Arledge T Ann Allergy Asthma Immunol; 1999 Feb; 82(2):205-11. PubMed ID: 10071526 [TBL] [Abstract][Full Text] [Related]
9. Salmeterol and fluticasone propionate given as a combination. Lack of systemic pharmacodynamic and pharmacokinetic interactions. Kirby S; Falcoz C; Daniel MJ; Milleri S; Squassante L; Ziviani L; Ventresca GP Eur J Clin Pharmacol; 2001; 56(11):781-91. PubMed ID: 11294367 [TBL] [Abstract][Full Text] [Related]
11. Salmeterol and fluticasone in young children with multiple-trigger wheeze. Mäkelä MJ; Malmberg LP; Csonka P; Klemola T; Kajosaari M; Pelkonen AS Ann Allergy Asthma Immunol; 2012 Jul; 109(1):65-70. PubMed ID: 22727160 [TBL] [Abstract][Full Text] [Related]
12. Inhaled salmeterol/fluticasone propionate combination: a review of its use in persistent asthma. Markham A; Jarvis B Drugs; 2000 Nov; 60(5):1207-33. PubMed ID: 11129128 [TBL] [Abstract][Full Text] [Related]
13. Tolerance to the bronchoprotective effect of salmeterol 12 hours after starting twice daily treatment. Drotar DE; Davis EE; Cockcroft DW Ann Allergy Asthma Immunol; 1998 Jan; 80(1):31-4. PubMed ID: 9475563 [TBL] [Abstract][Full Text] [Related]
14. Effect of long-term salmeterol therapy compared with as-needed albuterol use on airway hyperresponsiveness. Rosenthal RR; Busse WW; Kemp JP; Baker JW; Kalberg C; Emmett A; Rickard KA Chest; 1999 Sep; 116(3):595-602. PubMed ID: 10492259 [TBL] [Abstract][Full Text] [Related]
15. The effect of reducing the fine-particle mass of salmeterol from metered-dose inhalers on bronchodilatation and bronchoprotection against methacholine challenge: a randomized, placebo-controlled, double-blind, crossover study. Langley SJ; Allen D; McDonnell B; Wheeler N; Sharma RK; Sykes A; Woodcock A Clin Ther; 2005 Jul; 27(7):1004-12. PubMed ID: 16154479 [TBL] [Abstract][Full Text] [Related]
16. Salmeterol and fluticasone propionate combined in a new powder inhalation device for the treatment of asthma: a randomized, double-blind, placebo-controlled trial. Kavuru M; Melamed J; Gross G; Laforce C; House K; Prillaman B; Baitinger L; Woodring A; Shah T J Allergy Clin Immunol; 2000 Jun; 105(6 Pt 1):1108-16. PubMed ID: 10856143 [TBL] [Abstract][Full Text] [Related]
17. Salmeterol xinafoate as maintenance therapy compared with albuterol in patients with asthma. D'Alonzo GE; Nathan RA; Henochowicz S; Morris RJ; Ratner P; Rennard SI JAMA; 1994 May; 271(18):1412-6. PubMed ID: 7909853 [TBL] [Abstract][Full Text] [Related]
18. A comparison of beclomethasone, salmeterol, and placebo in children with asthma. Canadian Beclomethasone Dipropionate-Salmeterol Xinafoate Study Group. Simons FE N Engl J Med; 1997 Dec; 337(23):1659-65. PubMed ID: 9385125 [TBL] [Abstract][Full Text] [Related]
19. In vivo effect of albuterol on methacholine-contracted bronchi in conjunction with salmeterol and formoterol. Aziz I; Lipworth BJ J Allergy Clin Immunol; 1999 May; 103(5 Pt 1):816-22. PubMed ID: 10329815 [TBL] [Abstract][Full Text] [Related]
20. The protective effect of salbutamol inhaled using different devices on methacholine bronchoconstriction. Giannini D; Di Franco A; Bacci E; Dente FL; Taccola M; Vagaggini B; Paggiaro P Chest; 2000 May; 117(5):1319-23. PubMed ID: 10807817 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]